• Skyline Isolations

Safety of CBD in Children and Young Adults with Treatment-Resistant Epilepsy

ABSTRACT

Cannabidiol (CBD) is the most abundant non-psychoactive cannabinoid in the cannabis plant. Animal studies demonstrate anticonvulsant efficacy in multiple species and models. Anecdotal reports suggest efficacy in children with treatment-resistant epilepsies (TRE), including Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS). We report current results in our expanded access treatment program.

CLICK TO READ FULL STUDY

KEY WORDS: #CBD #Seizures #Neuropathic #TreatmentResistantEpilepsy #TRE #DravetSyndrome #LennoxGastautSyndrome

SOURCE: American Epilepsy Society

AUTHORS: Orrin Devinsky, Elizabeth Thiele, Linda Laux, Daniel Friedman, Anup Patel, Judith Bluvstein, Michael Chez, Charuta Joshi, Roberta Cilio, Francis Filloux, Evan Fertig, Angus Wilfong, Paul D. Lyons, Yong Park, Robert Flamini, Matthew Wong, Ian Miller, Eric Marsh

ABOUT

CONTACT US

SHOP

  • Skyline Isolations Instagram
  • Skyline Isolations Facebook
  • Skyline Pinterest
  • Skyline Isolations LinkedIn
  • Skyline Isolations Twitter

© 2017 by Skyline Isolations LLC

DISCLAIMER: SKYLINE DOES NOT MAKE ANY CLAIMS, BUT DISCUSSES PUBLICLY AVAILABLE ANECDOTAL EVIDENCE, RESOURCES AND BOTH EDUCATIONAL AND MEDICAL JOURNALS.

Products may have o.1% of THC content or less.